Bioavailability of curcumin: problems and promises.

@article{Anand2007BioavailabilityOC,
  title={Bioavailability of curcumin: problems and promises.},
  author={Preetha Anand and Ajaikumar B. Kunnumakkara and Robert A. Newman and Bharat Bhushan Aggarwal},
  journal={Molecular pharmaceutics},
  year={2007},
  volume={4 6},
  pages={
          807-18
        }
}
Curcumin, a polyphenolic compound derived from dietary spice turmeric, possesses diverse pharmacologic effects including anti-inflammatory, antioxidant, antiproliferative and antiangiogenic activities. Phase I clinical trials have shown that curcumin is safe even at high doses (12 g/day) in humans but exhibit poor bioavailability. Major reasons contributing to the low plasma and tissue levels of curcumin appear to be due to poor absorption, rapid metabolism, and rapid systemic elimination. To… Expand
Curcumin: a review
The main objective of this review article is to overcome or to improve the problems related with curcumin with the help of new technologies or modifications to make a promising therapeutic agentExpand
Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studies.
TLDR
The efficacy and safety of curcumin phytosomes have been shown against several human diseases including cancer, osteoarthritis, diabetic microangiopathy and retinopathy, and inflammatory diseases. Expand
Biodistribution of curcumin and its derivatives new aspects for curcumin administration
Curcumin, a polyphenolic compound derived from dietary spice turmeric, possesses diverse pharmacologic effects including antioxidant, anti-ininflammatory, antitumor and chemoprotective effects.Expand
Bioavailability and Metabolism of Curcuminoids
Curcuminoids are biologically active polyphenols present in the spice and coloring agent turmeric. Dietary intake of curcuminoids has been associated a wide range of medicinal properties, includingExpand
The Problem of Curcumin and Its Bioavailability: Could Its Gastrointestinal Influence Contribute to Its Overall Health-Enhancing Effects?
TLDR
It is proposed in this review that curcumin's potential as a therapeutic agent may not solely rely on its bioavailability, but rather its medicinal benefits may also arise from its positive influence on gastrointestinal health and function. Expand
Oral bioavailability of curcumin: problems and advancements
TLDR
Recent studies in the design and development of oral delivery systems for curcumin to enhance the solubility and oral bioavailability, including liposomes, nanoparticles and polymeric micelles, phospholipid complexes, and microemulsions are summarized. Expand
Recent developments in formulation design for improving oral bioavailability of curcumin: A review
Abstract Curcumin, a yellow-orange substance that is extracted from the spice turmeric (Curcuma longa, Zinziberaceae), has been attributed with a wide range of pharmacological activities for theExpand
Metabolism, Bioavailability, Biochemical Effects of Curcumin in Visceral Organs and the Brain
It is well known that curcumin produces antioxidant, anti-inflammatory, anticancer, antiviral, and antiarthritic properties. The poor bioavailability of curcumin is the major hurdle for its moreExpand
VARIOUS APPROACHES TOWARDS ENHANCEMENT OF BIOAVAILABILITY OF CURCUMIN – A POTENT PHYTOCHEMICAL
Herbal medicine is the oldest form of health care known to mankind. Turmaric (Curcuma longa Linn), a nature’s precious and most popular Indian spice belonging to family zingiberaceae is cultivatedExpand
Dietary Curcumin: Correlation between Bioavailability and Health Potential
TLDR
Several strategies such as inhibition of curcumin metabolism with adjuvants as well as novel solid and liquid oral delivery systems have been tried to counteractCurcumin poor absorption and rapid elimination from the body. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 84 REFERENCES
Clinical studies with curcumin.
TLDR
The preliminary results did support the efficacy of curcumin in patients with rheumatoid arthritis, inflammatory eye diseases, inflammatory bowel disease, chronic pancreatitis, psoriasis, hyperlipidemia, and cancers, but it is imperative that well-designed clinical trials, supported by better formulations ofCurcumin or novel routes of administration, be conducted in the near future. Expand
Phase I Clinical Trial of Oral Curcumin
TLDR
A daily oral dose of 3.6 g of curcumin is advocated for Phase II evaluation in the prevention or treatment of cancers outside the gastrointestinal tract in patients with advanced colorectal cancer refractory to standard chemotherapies. Expand
Anticancer potential of curcumin: preclinical and clinical studies.
TLDR
Evidence has also been presented to suggest that curcumin can suppress tumor initiation, promotion and metastasis, and Pharmacologically,Curcumin has been found to be safe. Expand
Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers.
TLDR
The study shows that in the dosages used, piperine enhances the serum concentration, extent of absorption and bioavailability of curcumin in both rats and humans with no adverse effects. Expand
Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine
TLDR
The results suggest that curcumin formulated with phosphatidylcholine furnishes higher systemic levels of parent agent than unformulatedCurcumin. Expand
Anti-tumour and antioxidant activity of natural curcuminoids.
TLDR
Curcumin III is the most active of the curcuminoids present in turmeric, indicated by the ability of these compounds to suppress the superoxide production by macrophages activated with phorbol-12-myristate-13-acetate (PMA). Expand
Dose escalation of a curcuminoid formulation
TLDR
The tolerance of curcumin in high single oral doses appears to be excellent, and these findings warrant further investigation for its utility as a long-term chemopreventive agent. Expand
Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer
TLDR
A series of novel curcumin analogues were synthesized and screened for anticancer activity and exhibited neither harmful nor growth-suppressive effects on normal hepatocytes where oncogene products are not activated, suggesting that they may provide effective alternative therapies for the prevention and treatment of some human cancers. Expand
Highly active anticancer curcumin analogues.
TLDR
Both simple curcumin analogues and the protein conjugate evidence antiangiogenic activity in cell culture, which implies that the fVIIa-TF targeting process, like the dienone drugs, permits a double-pronged attack with the potential to destroy a tumor directly by apoptosis. Expand
Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer.
TLDR
The results suggest that Curcuma extract can be administered safely to patients at doses of up to 2.2 g daily, equivalent to 180 mg of curcumin, and that larger clinical trials ofcurcumin has low oral bioavailability in humans and may undergo intestinal metabolism. Expand
...
1
2
3
4
5
...